Login / Signup
Christopher M Dennehy
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Poor Prognosis
Small Molecule
Radical Prostatectomy
Endoplasmic Reticulum Stress
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mannan Nouri
,
Andreas Varkaris
,
Maya Ridinger
,
Susan L Dalrymple
,
Christopher M Dennehy
,
John T Isaacs
,
David J Einstein
,
W Nathaniel Brennen
,
Steven P Balk
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.
Molecular cancer therapeutics
(2024)
Mannan Nouri
,
Andreas Varkaris
,
Maya Ridinger
,
Susan L Dalrymple
,
Christopher M Dennehy
,
John T Isaacs
,
David J Einstein
,
W Nathaniel Brennen
,
Steven P Balk
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.
Molecular cancer therapeutics
(2024)